Biopharma Annual Planning Success: Close Your Rings Year-Round
How do we think about biopharma annual planning differently? The analogy we…
The Power of Target Product Profiles: Three Case Studies
In the biopharma industry, the Target Product Profile (TPP) is a critical tool…
Unlocking Success: The Power of Target Product Profiles
In the ever-evolving biopharma landscape, success hinges not just on innovation…
Unfinished Business on the Glass Ceiling
Reflecting on my career and the significant societal and technological shifts…
Rare Diseases: Shaping Biopharma’s Future from the Past
We just completed Rare Disease month. With that in mind, Sue has asked me to step in for today’s e-conversation, as this topic is very much a part of…
“Rare Disease” Is More Than Just a Day
You might think it odd for me to begin this month’s e-conversation with a quote from a Supreme Court justice. However, this insight has stuck with me…
Patient Advocacy – Delivering on Patient Centricity in Drug Development
Historically, biopharma companies developed drugs for patients with an illness — but the illness was the primary focus. In recent years, much has…
Survival in Uncertain Times
Like so many seasoned industry professionals, we eagerly seek thought leader perspectives — on the current biopharma industry landscape; the…
Professionalism Still Matters
Sadly, another summer is coming to a close. If you have school-aged kids at home, you are undoubtedly already taking steps to shake them out of…
Be Bold, Be Empowered
Coming up the ranks in various roles, I remember feeling frustrated at times when leadership would not “decide” or “give direction.” We were all…
Optimize Your Congress Planning
Regardless of your company or drug development stage, congress events are critical undertakings; they represent both a substantial opportunity and a…